Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.5.1.18 (
glutathione S-transferase
)
22,582
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
LCPTP
(leucocyte-phosphotyrosine phosphatase) is a 42kDa protein tyrosine phosphatase expressed predominantly in haematopoietic cells which has been implicated in the early stages of the T cell receptor signalling pathway. The substrates of
LCPTP
have been shown to include MAP kinase family members, but it remains unclear whether
LCPTP
is found in stable constitutive association with these enzymes, or associates transiently during dephosphorylation. Here we report on
LCPTP
/MAP kinase interactions in CD3-stimulated Jurkat T cells. Pull-downs from Jurkat T cells using a recombinant
GST
-
LCPTP
substrate-trap protein, but not wild-type
LCPTP
show a clear specific association with both ERK1 and ERK2. In Jurkat cells overexpressing
LCPTP
, a small fraction of cell ERK1 can be immunoprecipitated in stable association with
LCPTP
. However, in both unstimulated and anti-CD3 antibody stimulated Jurkat T cells, we were unable to demonstrate any constitutive interaction between endogenous
LCPTP
and any MAP kinase family members. We propose that both ERK1 and ERK2 interact transiently with
LCPTP
as substrates for the phosphatase rather than as constitutive protein partners.
...
PMID:LCPTP-MAP kinase interaction: permanent partners or transient associates? 1241 99